A Biotech Manager's Handbook

List of figures and tables

Figures

1.1. Pharmaceutical investment in R&D 10

1.2. Cost of drug development by phase per compound 11

1.3. R&D spending by pharmaceutical companies versus new product approvals 12

1.4. Novel drug development timelines are lengthening 15

3.1. Situational approach to leadership 73

4.1. The Johari window 85

4.2. Hidden management: most of the really important stuff in management is invisible and intangible 94

5.1. Planning hierarchy from vision to action 119

6.1. Funding sources used by UK therapeutics firms 137

6.2. Cumulative investment versus expected returns in a hypothetical VC-backed firm 144

7.1. Raising funds - cash flow forecasting and financial management activities 165

8.1. An outline of patent procedures ...